|Articles|July 29, 2022
TrialCard Names Scott Dulitz Chief Executive Officer
Advertisement
TrialCard Incorporated, a full-service life sciences commercialization partner, today announced that Scott Dulitz has been promoted to Chief Executive Officer by the Company's Board of Directors. Mr. Dulitz, a twenty-year veteran of the pharma services industry, joined TrialCard in 2015 and most recently served as President and Chief Strategy Officer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
2
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
3
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms
4
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
5